explore -WSS

explore

author：leisure time 2025-10-01 00:46:47 - browse：4

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Beam Therapeutics to lay off 20% of its staff, re

knowledge

entertainment

WSS

Supreme Court rules employers must be more accommodating of religious observance

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Supreme Court rules employers must be more accommodating of religious observance

Tuskegee Airman Raymond Cassagnol dies at 102

Hospital price transparency does save money, advocate argues

How climate

focus

explore

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Studies point to risks of excluding people with obesity from drug trials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT Readout Newsletter: Today's biggest biotech updates

In Memoriam: Notable people who died in 2023

Beam Therapeutics to lay off 20% of its staff, re

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Readout Newsletter: Today's biggest biotech updates

As demand for Covid shots wanes, Moderna seeks its next success

Tuskegee Airman Raymond Cassagnol dies at 102

explore

Why do we get seasonal allergies?

Medical experts exlpore how to eliminate bias in clinical algorithms

Ukrainian soldiers say they owe lives to US

Medicare reduced heart disease by changing how it pays doctors

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

FDA gives detailed accounting of AI

knowledge

hotspot

entertainment

entertainment